experimental group:This study adopted a dose escalation design. Each subject received only one corresponding dose. The dose escalation started from a low dose and was conducted on a case-by-case basis

2 trials

Sponsors

West China Hospital, Sichuan University

Conditions

Treatment-Resistant Depression

Phase 1

Clinical Study on the Use of Nasal Spray Recombinant Adeno- Associated Virus Drug JWK013 for Treating Treatment-Resistant Depressive Disorder

Active, not recruitingChiCTR2600123780

West China Hospital, Sichuan UniversityTreatment-Resistant Depression

Start: 2026-04-30Updated: 2026-05-04

Unknown Phase

Clinical Study on the Use of Nasal Spray Recombinant Adeno- Associated Virus Drug JWK012 for Treating Treatment-Resistant Depressive Disorder

Active, not recruitingChiCTR2600123441

West China Hospital, Sichuan UniversityTreatment-Resistant Depression

Start: 2026-04-30Updated: 2026-05-04